0000891293-15-000059.txt : 20151120 0000891293-15-000059.hdr.sgml : 20151120 20151120173939 ACCESSION NUMBER: 0000891293-15-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151119 FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIANCO LOUIS A CENTRAL INDEX KEY: 0001204260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151247655 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-11-19 0 0000891293 CTI BIOPHARMA CORP ctic 0001204260 BIANCO LOUIS A 3101 WESTERN AVE SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Finance & Administration Common Stock 2015-11-19 4 S 0 800 1.1 D 920547 D Common Stock 2015-11-19 4 S 0 1400 1.105 D 919147 D Common Stock 2015-11-19 4 S 0 3800 1.11 D 915347 D Common Stock 2015-11-19 4 S 0 200 1.115 D 915147 D Common Stock 2015-11-19 4 S 0 1000 1.12 D 914147 D Common Stock 2015-11-19 4 S 0 1000 1.125 D 913147 D Common Stock 2015-11-19 4 S 0 1200 1.13 D 911947 D Common Stock 2015-11-19 4 S 0 100 1.135 D 911847 D Common Stock 2015-11-19 4 S 0 806 1.14 D 911041 D Common Stock 2015-11-19 4 S 0 2994 1.145 D 908047 D Common Stock 2015-11-19 4 S 0 500 1.15 D 907547 D Common Stock 2015-11-19 4 S 0 1100 1.155 D 906447 D Common Stock 2015-11-19 4 S 0 100 1.16 D 906347 D Common Stock 37 I Trust for children The sale was effected pursuant to a Rule 10b5-1 trading plan. Louis A. Bianco 2015-11-20